by DAVID.KIEWLICH | Aug 13, 2026 | Biotech
Biotech is the cutting edge of human advancement. Gene therapies are curing rare diseases. Cell-based immunotherapies are redefining oncology. Carbon-capturing biology and engineered materials are shaping climate change. The research has never been more exciting. Yet...
by DAVID.KIEWLICH | Aug 7, 2026 | Biotech
Nearly 90% of biotech startups fail. This number is so ingrained in biotech that almost everyone treats it as a given. But maybe we are looking at things backwards. What if failing wasn’t the opposite of success, but what you needed to get there? At BADASS Labs, our...
by DAVID.KIEWLICH | Jul 31, 2026 | Biotech
You have the science. You have the vision. You may even have a handful of early results that make your blood boil at 3 a.m. And yet, as a biotech founder, the hardest task is probably the first one that gets you up in the morning: fundraising. Raising money for a...
by DAVID.KIEWLICH | Jul 30, 2026 | Biotech
Let’s be blunt: biotech funding in 2026 is not about great science anymore. It is about proven science. Venture capitalists are actively seeking out biotechs with existing data sets and de-risked pipelines; the days of backing a tantalizing hypothesis and a...
by DAVID.KIEWLICH | Jul 23, 2026 | Biotech
The uncomfortable fact that many VCs prefer not to discuss is this: the climate-saving technology that will eventually define our industry won’t originate in a SoMa software firm. It will likely be discovered in a wet lab by scientists manipulating bacteria and...
by DAVID.KIEWLICH | Jul 17, 2026 | Biotech
Got the passion and the brilliant idea? Do you know that the odds of turning your great scientific idea into a market-ready business are pretty slim? That’s because there’s simply no good access to lab space in the biotech space. For far too long, many of our best...